GeneDx names Mark Gardner President
He joins from Quest Diagnostics to lead commercial and operations teams, focusing on execution and efficient scaling.
Latest GeneDx News & Updates
See the latest news and media coverage for GeneDx. We track all announcements, press releases, and industry mentions in real time, all in one place.
Genetic testing and genomic sequencing company
genedx.com- Headquarters
- Stamford, United States
- Company type
- Public company
- Number of employees
- 1,200–5,000
Last updated
Latest news about GeneDx
In short: GeneDx achieved record revenue growth, announced the acquisition of Fabric Genomics, and appointed Mark Gardner as President.
Company announcements
GeneDx reports first quarter 2026 financial results and updates outlook
Revenue reached $102.3 million with 27% exome and genome revenue growth. Full-year guidance revised to $475-490 million.
GeneDx study shows $80,000 per child cost savings
The SAVES-Kids study found up to 61% reduction in healthcare costs for children with neurodevelopmental disorders after testing.
GeneDx will present 18 abstracts at ACMG 2026
The presentations highlight GeneDx's leadership in exome and genome quality, expanded access, and AI-driven innovations.
Media coverage
... ACTION REMINDER: Faruqi & Faruqi, LLP Reminds GeneDx (WGS) Investors of...
If you purchased or acquired securities in GeneDx between April 16, 2025 and May 4, 2026 and would like to discuss your legal rights, call...
WGS DEADLINE: Levi & Korsinsky Reminds GeneDx Holdings Corp. Investors of...
Levi & Korsinsky, LLP alerts investors in GeneDx Holdings Corp. (NASDAQ: WGS) that two senior executives are named as individual defendants in a securities class...
WGS Shareholder Alert: GeneDx Holdings Corp. Securities Class Action Lawsuit - Investors Should Contact SueWallSt
/PRNewswire/ -- IMPORTANT DATE: August 3, 2026. Investors who purchased GeneDx Holdings Corp. (NASDAQ: WGS) securities between April 16, 2025 and May 4, 2026...
Guggenheim Reaffirmed Buy on GeneDx at October End, Lifted Price Target to $170 After Q3 Beat
GeneDx Holdings Corp. (NASDAQ:WGS) is one of the best digital health stocks to buy now. On October 29, 2025, Guggenheim lifted GeneDx (NASDAQ:WGS) to a...
Never miss news about GeneDx
Track GeneDx and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
GeneDx competitors & trending companies
Browse news for competitors to GeneDx and other trending companies.
Tempus
Invitae
Guardant Health
Natera
MyOme
Tagsen
Aura Print
GAP
Brandon Hire Station
HSS
Lynch
Nixon
Jarvie Plant
Huws Gray
Nationwide Hire Solutions
Boels
Freenome
Exact Sciences
GRAIL
Whataburger
FSG
Insomnia Cookies
Avelo
Champion
NGPS
Impact Property Solutions
TRIO
Everflow
Inkmonk
ShiftKey
Bardstown Bourbon
symplr
New Age Industrial
Zywave
Racing America
Metro Vein Centers